Intravenous Solutions Market Report
By Research Impact Technologies
Global Industry Analysis Market Research Report on Intravenous Solutions
– RI Technologies believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data.
For Discount Queries –
contactus@researchimpact.com
Intravenous Solutions Market research report is analyzed by Type and Nutrients for each of the geographic regions-North America, Europe, Asia-Pacific and Rest of World. The global Intravenous solutions market size includes by Type- Partial Parenteral Nutrition (PPN) & Total Parenteral Nutrition (TPN); by Nutrients-Carbohydrates, Salt and Electrolytes, Minerals and Vitamins and Amino Acids. Estimations and predictions for the total global IV solutions market are given by geographic regions. Business profiles of 13 major companies are discussed in the report. The report covers more than 170 companies that are engaged in IV Solutions and related products. Major Contract Research Organizations serving Intra venous Solution market are also covered in the Corporate Directory section of this report. Information related to product developments, partnerships, collaborations, and mergers and acquisitions is also included in the report. A total of 124 exclusive graphically represented exhibits complement the text.
Several companies that supply intravenous solutions have come up with innovations in their product lines. An industry leader in this field, Baxter International, rapidly expanded its product line of pre-mixed frozen intravenous solutions. Abbot Labs designed a system in which bottles of powdered drugs could be directly introduced into the bag of intravenous fluid as required. The lids of these bottles are screwed open inside the sterile bags and the drugs are subsequently introduced into the solution and mixed by shaking. Intravenous feeding is the short-term administration of supplementary nutrients through a solution that is introduced into the vein. Peripheral intravenous feeding refers to infusion of the fluid in a small vein on the surface of an arm, leg or the scalp. On the other hand, central venous feeding refers to infusion into a large vein which is embedded deep within a body. Only limited quantities of nutrients can be administered through peripheral intravenous feeding as there is the danger of incurring phlebitis and/or clots (thrombi) if concentrated solutions are used. However, in central venous feeding it is possible to infuse concentration nutrient solutions as the rapid blood flow in the central veins can promptly dilute the solution thereby minimizing the possibility of causing irritation to the vein. When IV solutions are produced locally in medically emerging countries, the resulting return on initial investments can be quite small. It is estimated that profitability would stand at only 50% of the total production capacity. The production costs that are incurred in developing IV solutions are 45% to 65% lower than the existing market price for primary product lines. These estimates are based on U.S. cost figures. When the U.S. system of calculation is used, both direct and indirect labor costs are the largest cost factors. However, in developing nations, the labor cost is relatively low and the cost of IV solutions is much higher. Therefore, the actual production cost can be estimated to be 60% to 90% lower than the market price of the product. There is a very high demand for IV solutions. Therefore, even if a situation arises in which production is more than the local demand, there are still excellent prospects of making national sales as well as sales through exports. The raw materials that are required to produce IV solutions are easy to procure as they are readily available in local markets.
This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.
Synopsis of the report summarizes the global Intravenous Solutions market by Type and Nutrient. Global historic, current and future markets is analyzed in US$, from 2010 through 2022. A List of major companies is also provided.
Market Dynamics chapter provides information on global markets for Intravenous Solutions. The chapter includes global market analysis (in US$, from 2010 through 2022) by geographic regions (North America, Europe, Asia-Pacific and Rest of World); analysis of each region by both Type and Nutrient. Countries covered includes US, Canada, UK, Germany, France, Switzerland, Russia, Japan, China, India, Australia, South Korea, Brazil, Israel and South Africa. The section includes key market trends and an industry outlook.
The chapter covers brief business profiles of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc.
This chapter gives an insight into Intravenous Solutions market through definitions, segmentation and applications. The chapter also includes product trends and potential opportunities. Various research activities in the field of Intravenous Solutions find a mention in this chapter.
This chapter provides a global region-wise list of 170+ companies, CROs/CMOs and academic institutions that offer Intravenous Solutions products and/or services.
This chapter provides a compilation of worldwide patents related to Intravenous Solutions products/technologies.
Amanta Healthcare Ltd. (India)
B. Braun Melsungen AG (Germany)
Baxter (India) Pvt. Ltd. (India)
Baxter International, Inc. (USA)
Fresenius Kabi AG (Germany)
Hospira, Inc. (USA)
Laboratorios Grifols SA (Spain)
Liqvor Pharmaceuticals (Armenia)
Otsuka Pharmaceutical Co., Ltd. (Japan)
Otsuka Pharmaceutical Private Ltd. (India)
Sichuan Kelun Pharmaceutical Co., Ltd. (China)
Sino-Swed Pharmaceutical Corp., Ltd. (China)
Terumo Corporation (Japan)
1. SCOPE AND METHODOLOGY
Scope of the Study
Research Methodology
Units and Currency
2. REPORT SYNOPSIS
2.1 Introduction
History
Definitions
Intravenous
Intravenous Infusions
Parenteral
Enteral
Home Parenteral Nutrition (HPN)
Partial Parenteral Nutrition (PPN)
Total Parenteral Nutrition (TPN)
Benefits
Hazards of Intravenous Feeding
2.2 Segmentation of Intravenous Solutions
Exhibit 1. Segmentation of Intravenous Solutions Market by Type and Nutrients
2.3 Intravenous Solutions - Global Market Analysis
Exhibit 2. Intravenous Solutions - Global Historic Market (2000-2014) in US$ Million
Exhibit 3. Intravenous Solutions - Global Market - Current and Forecast (2015 - 2022) in US$ Million
Exhibit 4. List of Major Global Companies in Intravenous Solutions Market
3. MARKET DYNAMICS
3.1 Market Overview
Economic Profile
Market Growth Factors
Healthcare Costs
Exhibit 5. Global Estimated Healthcare Spending (% of GDP) for 2018
Exhibit 6. Global Estimated Healthcare Spending in US$ Billion for 2018
3.2 Global Intravenous Solutions Market Analysis
Hospital Beds Trigger Demand for Intravenous Solutions
Exhibit 7. Hospital Bed Density (2013) Per Thousand Population
Exhibit 8. Intravenous Solutions - Global Historic Market (2000-2014) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Million
Exhibit 9. Intravenous Solutions - Global Market - Current and Forecast (2015 - 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Million
Exhibit 10. Intravenous Solutions - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World
3.3 North American Intravenous Solutions Market Analysis
Exhibit 11. Intravenous Solutions - North American Market - Historic, Current, and Forecast (2010 - 2022) by Country for United States and Canada in US$ Million
Exhibit 12. Intravenous Solutions – North American Market Shares (2012, 2018 & 2022) by Country for United States and Canada
3.3 (I) US Intravenous Solutions Market
3.3 (II) Canadian Intravenous Solutions Market
Competitor Overview
United States
Exhibit 13. List of Major United States Intravenous Solutions Companies
Canada
3.4 European Intravenous Solutions Market Analysis
Exhibit 14. Intravenous Solutions - European Market - Historic, Current, and Forecast (2010 - 2022) by Country for Germany, France, United Kingdom, Italy, Spain, Russia and Rest of Europe in US$ Million
Exhibit 15. Intravenous Solutions - European Market Shares (2012, 2018 & 2022) by Country for Germany, France, United Kingdom, Italy, Spain, Russia and Rest of Europe
3.4 (I) German Intravenous Solutions Market
3.4 (II) French Intravenous Solutions Market
3.4 (III) UK Intravenous Solutions Market
3.4 (IV) Italian Intravenous Solutions Market
3.4 (V) Spanish Intravenous Solutions Market
3.4 (VI) Russian Intravenous Solutions Market
3.4 (VII) Rest of European Intravenous Solutions Market
Competitor Overview
Exhibit 16. List of Major European Intravenous Solutions Companies
Germany
United Kingdom
Italy
Spain
Russia
Rest of Europe
3.5 Asia-Pacific Intravenous Solutions Market Analysis
Exhibit 17. Intravenous Solutions - Asia-Pacific Market - Historic, Current, and Forecast (2010 - 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 18. Intravenous Solutions - Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific
3.5 (I) Chinese Intravenous Solutions Market
3.5 (II) Indian Intravenous Solutions Market
3.5 (III) Japanese Intravenous Solutions Market
3.5 (IV) Australian Intravenous Solutions Market
3.5 (V) South Korean Intravenous Solutions Market
3.5 (VI) Rest of Asia-Pacific Intravenous Solutions Market
Competitor Overview
Exhibit 19. List of Major Asia-Pacific Intravenous Solutions Companies
China
India
South Korea
3.6 Latin American Intravenous Solutions Market Analysis
Exhibit 20. Intravenous Solutions – Latin American Market - Historic, Current, and Forecast (2010 - 2022) by Country for Brazil, Mexico and Rest of Latin America in US$ Million
Exhibit 21. Intravenous Solutions – Intravenous Solutions – Latin American Market Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America
3.6 (I) Brazilian Intravenous Solutions Market
3.6 (II) Mexican Intravenous Solutions Market
3.6 (III) Rest of Latin America Intravenous Solutions Market
Competitor Overview
3.7 Rest of World Intravenous Solutions Market Analysis
Exhibit 22. Intravenous Solutions - Rest of World Market - Historic, Current, and Forecast (2010 - 2022) by Country for South Africa, Israel and Other Countries in US$ Million
Exhibit 23. Intravenous Solutions - Rest of World Market Shares (2012, 2018 & 2022) by Country for South Africa, Israel and Other Countries
3.7 (I) South African Intravenous Solutions Market
3.7 (II) Israeli Intravenous Solutions Market
3.7 (III) Other Countries Intravenous Solutions Market
Competitor Overview
3.8 Analysis by Type
Exhibit 24. Intravenous Solutions by Type - Global Historic Market (2000-2014) for PPN and TPN in US$ Million
Exhibit 25. Intravenous Solutions by Type - Global Market - Current and Forecast (2015 - 2022) for PPN and TPN in US$ Million
Exhibit 26. Intravenous Solutions by Type - Global Market Shares (2012, 2018 & 2022) for PPN and TPN
3.8.1 Partial Parenteral Nutrition
3.8.1.1 Global Market for Partial Parenteral Nutrition
Exhibit 27. Partial Parenteral Nutrition - Global Market - Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Million
Exhibit 28. Partial Parenteral Nutrition - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World
3.8.1.2 North American Market for Partial Parenteral Nutrition
Exhibit 29. Partial Parenteral Nutrition - North American Market - Historic, Current, and Forecast (2010 - 2022) by Country for US and Canada in US$ Million
Exhibit 30. Partial Parenteral Nutrition - North American Market Shares (2012, 2018 & 2022) by Country US and Canada
3.8.1.3 European Market for Partial Parenteral Nutrition
Exhibit 31. Partial Parenteral Nutrition - European Market - Historic, Current, and Forecast (2010 - 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 32. Partial Parenteral Nutrition - European Market Shares (2012, 2018 & 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.8.1.4 Asia-Pacific Market for Partial Parenteral Nutrition
Exhibit 33. Partial Parenteral Nutrition - Asia-Pacific Market - Historic, Current, and Forecast (2010 - 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 34. Partial Parenteral Nutrition - Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific
3.8.1.5 Latin American Market for Partial Parenteral Nutrition
Exhibit 35. Partial Parenteral Nutrition – Latin Americna Market - Historic, Current, and Forecast (2010 - 2022) by Country for Brazil, Mexcio and Rest of Latin America in US$ Million
Exhibit 36. Partial Parenteral Nutrition – Latin American Market Shares (2012, 2018 & 2022) by Country for Brazil, Mexcio and Rest of Latin America
3.8.1.6 Rest of World Market for Partial Parenteral Nutrition
Exhibit 37. Partial Parenteral Nutrition - Rest of World Market - Historic, Current, and Forecast (2010 - 2022) by Country for South Africa, Israel and Other Countries in US$ Million
Exhibit 38. Partial Parenteral Nutrition - Rest of World Market Shares (2012, 2018 & 2022) by Country for South Africa, Israel and Other Countries
3.8.2 Total Parenteral Nutrition
3.8.2.1 Global Market for Total Parenteral Nutrition
Exhibit 39. Total Parenteral Nutrition - Global Market - Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Million
Exhibit 40. Total Parenteral Nutrition - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World
3.8.2.2 North American Market for Total Parenteral Nutrition
Exhibit 41. Total Parenteral Nutrition - North American Market - Historic, Current, and Forecast (2010 - 2022) by Country for US and Canada in US$ Million
Exhibit 42. Total Parenteral Nutrition - North American Market Shares (2012, 2018 & 2022) by Country for US and Canada
3.8.2.3 European Market for Total Parenteral Nutrition
Exhibit 43. Total Parenteral Nutrition - European Market - Historic, Current, and Forecast (2010 - 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 44. Total Parenteral Nutrition - European Market Shares (2012, 2018 & 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.8.2.4 Asia-Pacific Market for Total Parenteral Nutrition
Exhibit 45. Total Parenteral Nutrition - Asia-Pacific Market - Historic, Current, and Forecast (2010 - 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 46. Total Parenteral Nutrition - Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific
3.8.2.5 Latin American Market for Total Parenteral Nutrition
Exhibit 47. Total Parenteral Nutrition – Latin American Market - Historic, Current, and Forecast (2010 - 2022) by Country for Brazil, Mexico and Rest of Latin America in US$ Million
Exhibit 48. Total Parenteral Nutrition – Latin American Market Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America
3.8.2.6 Rest of World Market for Total Parenteral Nutrition
Exhibit 49. Total Parenteral Nutrition - Rest of World Market - Historic, Current, and Forecast (2010 - 2022) by Country for South Africa, Israel and Other Countries in US$ Million
Exhibit 50. Total Parenteral Nutrition - Rest of World Market Shares (2012, 2018 & 2022) by Country for South Africa, Israel and Other Countries
3.9 Analysis by Nutrients
Exhibit 51. Intravenous Solutions by Nutrients - Global Historic Market (2000-2014) for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids and Other in US$ Million
Exhibit 52. Intravenous Solutions by Nutrients - Global Market - Current and Forecast (2015 - 2022) for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids s and Other in US$ Million
Exhibit 53. Intravenous Solutions by Nutrients - Global Market Shares (2012, 2018 & 2022) for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids s and Other
3.9.1 Carbohydrates
3.9.1.1 Global Carbohydrate based Intravenous Solutions Market
Exhibit 54. Carbohydrate based Intravenous Solutions - Global Market - Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Million
Exhibit 55. Carbohydrate based Intravenous Solutions - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World
3.9.1.2 North American Carbohydrate based Intravenous Solutions Market
Exhibit 56. Carbohydrate based Intravenous Solutions - North American Market - Historic, Current, and Forecast (2010 - 2022) by Country for US and Canada in US$ Million
Exhibit 57. Carbohydrate based Intravenous Solutions - North American Market Shares (2012, 2018 & 2022) by Country for US and Canada
3.9.1.3 European Carbohydrate based Intravenous Solutions Market
Exhibit 58. Carbohydrate based Intravenous Solutions - European Market - Historic, Current, and Forecast (2010 - 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 59. Carbohydrate based Intravenous Solutions - European Market Shares (2012, 2018 & 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.9.1.4 Asia-Pacific Carbohydrate based Intravenous Solutions Market
Exhibit 60. Carbohydrate based Intravenous Solutions - Asia-Pacific Market - Historic, Current, and Forecast (2010 - 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 61. Carbohydrate based Intravenous Solutions - Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific
3.9.1.5 Latin American Carbohydrate based Intravenous Solutions Market
Exhibit 62. Carbohydrate based Intravenous Solutions – Latin American Market - Historic, Current, and Forecast (2010 - 2022) by Country for Brazil, Mexico and Rest of Latin America in US$ Million
Exhibit 63. Carbohydrate based Intravenous Solutions – Latin American Market Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America
3.9.1.6 Rest of World Carbohydrate based Intravenous Solutions Market
Exhibit 64. Carbohydrate based Intravenous Solutions - Rest of World Market - Historic, Current, and Forecast (2010 - 2022) by Country for South Africa, Israel and Other Countries in US$ Million
Exhibit 65. Carbohydrate based Intravenous Solutions - Rest of World Market Shares (2012, 2018 & 2022) by Country for South Africa, Israel and Other Countries
3.9.2 Salt and Electrolytes
3.9.2.1 Global Salt and Electrolytes based Intravenous Solutions Market
Exhibit 66. Salt and Electrolytes based Intravenous Solutions - Global Market - Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Million
Exhibit 67. Salt and Electrolytes based Intravenous Solutions - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World
3.9.2.2 North American Salt and Electrolytes based Intravenous Solutions Market
Exhibit 68. Salt and Electrolytes based Intravenous Solutions - North American Market - Historic, Current, and Forecast (2010 - 2022) by Country for US and Canada in US$ Million
Exhibit 69. Salt and Electrolyte based Intravenous Solutions - North American Market Shares (2012, 2018 & 2022) by Country for US and Canada
3.9.2.3 European Salt and Electrolytes based Intravenous Solutions Market
Exhibit 70. Salt and Electrolytes based Intravenous Solutions - European Market - Historic, Current, and Forecast (2010 - 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 71. Salt and Electrolytes based Intravenous Solutions - European Market Shares (2012, 2018 & 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.9.2.4 Asia-Pacific Salt and Electrolytes based Intravenous Solutions Market
Exhibit 72. Salt and Electrolytes based Intravenous Solutions - Asia-Pacific Market - Historic, Current, and Forecast (2010 - 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 73. Salt and Electrolytes based Intravenous Solutions - Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific
3.9.2.5 Latin American Salt and Electrolytes based Intravenous Solutions Market
Exhibit 74. Salt and Electrolytes based Intravenous Solutions – Latin American Market - Historic, Current, and Forecast (2010 - 2022) by Country for Brazil, Mexico and Rest of Latin America in US$ Million
Exhibit 75. Salt and Electrolytes based Intravenous Solutions - Latin American Market Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America
3.9.2.6 Rest of World Salt and Electrolytes based Intravenous Solutions Market
Exhibit 76. Salt and Electrolytes based Intravenous Solutions - Rest of World Market - Historic, Current, and Forecast (2010 - 2022) by Country for South Africa, Israel and Other Countries in US$ Million
Exhibit 77. Salt and Electrolytes based Intravenous Solutions - Rest of World Market Shares (2012, 2018 & 2022) by Country for South Africa, Israel and Other Countries
3.9.3 Mineral and Vitamin
3.9.3.1 Global Minerals and Vitamins based Intravenous Solutions Market
Exhibit 78. Minerals and Vitamins based Intravenous Solutions - Global Market - Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Million
Exhibit 79. Minerals and Vitamins based Intravenous Solutions - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World
3.9.3.2 North American Minerals and Vitamins based Intravenous Solutions Market
Exhibit 80. Minerals and Vitamins based Intravenous Solutions - North American Market - Historic, Current, and Forecast (2010 - 2022) by Country for US and Canada in US$ Million
Exhibit 81. Minerals and Vitamins based Intravenous Solutions - North American Market Shares (2012, 2018 & 2022) by Country for US and Canada
3.9.3.3 European Minerals and Vitamins based Intravenous Solutions Market
Exhibit 82. Minerals and Vitamins based Intravenous Solutions - European Market - Historic, Current, and Forecast (2010 - 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 83. Minerals and Vitamins based Intravenous Solutions - European Market Shares (2012, 2018 & 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.9.3.4 Asia-Pacific Minerals and Vitamins based Intravenous Solutions Market
Exhibit 84. Minerals and Vitamins based Intravenous Solutions - Asia-Pacific Market - Historic, Current, and Forecast (2010 - 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 85. Minerals and Vitamins based Intravenous Solutions - Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific
3.9.3.5 Latin American Minerals and Vitamins based Intravenous Solutions Market
Exhibit 86. Minerals and Vitamins based Intravenous Solutions - Latin American Market - Historic, Current, and Forecast (2010 - 2022) by Country for Brazil, Mexico and Rest of Latin America in US$ Million
Exhibit 87. Minerals and Vitamins based Intravenous Solutions - Latin American Market Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America
3.9.3.6 Rest of World Minerals and Vitamins based Intravenous Solutions Market
Exhibit 88. Minerals and Vitamins based Intravenous Solutions - Rest of World Market - Historic, Current, and Forecast (2010 - 2022) by Country for South Africa, Israel and Other Countries in US$ Million
Exhibit 89. Minerals and Vitamins based Intravenous Solutions - Rest of World Market Shares (2012, 2018 & 2022) by Country for South Africa, Israel and Other Countries
3.9.4 Amino Acids
3.9.4.1 Global Amino-Acids based Intravenous Solutions Market
Exhibit 90. Amino Acids based Intravenous Solutions - Global Market - Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Million
Exhibit 91. Amino Acids based Intravenous Solutions - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World
3.9.4.2 North American Amino Acids based Intravenous Solutions Market
Exhibit 92. Amino Acids based Intravenous Solutions - North American Market - Historic, Current, and Forecast (2010 - 2022) by Country for US and Canada in US$ Million
Exhibit 93. Amino Acids based Intravenous Solutions - North American Market Shares (2012, 2018 & 2022) by Country for US and Canada
3.9.4.3 European Amino Acids based Intravenous Solutions Market
Exhibit 94. Amino Acids based Intravenous Solutions - European Market - Historic, Current, and Forecast (2010 - 2022) by Country for Germany, France, UK, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 95. Amino Acids based Intravenous Solutions - European Market Shares (2012, 2018 & 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.9.4.4 Asia-Pacific Amino Acids based Intravenous Solutions Market
Exhibit 96. Amino Acids based Intravenous Solutions - Asia-Pacific Market - Historic, Current, and Forecast (2010 - 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 97. Amino Acids based Intravenous Solutions - Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific
3.9.4.5 Latin American Amino Acids based Intravenous Solutions Market
Exhibit 98. Amino Acids based Intravenous Solutions - Latin American Market - Historic, Current, and Forecast (2010 - 2022) by Country for Brazil, Mexico and Rest of Latin America in US$ Million
Exhibit 99. Amino Acids based Intravenous Solutions - Latin American Market Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America
3.9.4.6 Rest of World Amino Acids based Intravenous Solutions Market
Exhibit 100. Amino Acids based Intravenous Solutions - Rest of World Market - Historic, Current, and Forecast (2010 - 2022) by Country for South Africa, Israel and Other Countries in US$ Million
Exhibit 101. Amino Acids based Intravenous Solutions - Rest of World Market Shares (2012, 2018 & 2022) by Country for South Africa, Israel and Other Countries
3.9.5 Other Nutrients
3.9.5.1 Global Other Nutrients based Intravenous Solutions Market
Exhibit 102. Other Nutrients based Intravenous Solutions - Global Market - Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Million
Exhibit 103. Other Nutrients based Intravenous Solutions - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World
3.9.5.2 North American Other Nutrients based Intravenous Solutions Market
Exhibit 104. Other Nutrients based Intravenous Solutions - North American Market - Historic, Current, and Forecast (2010 - 2022) by Country for US and Canada in US$ Million
Exhibit 105. Other Nutrients based Intravenous Solutions - North American Market Shares (2012, 2018 & 2022) by Country for US and Canada
3.9.5.3 European Other Nutrients based Intravenous Solutions Market
Exhibit 106. Other Nutrients based Intravenous Solutions - European Market - Historic, Current, and Forecast (2010 - 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 107. Other Nutrients based Intravenous Solutions - European Market Shares (2012, 2018 & 2022) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.9.5.4 Asia-Pacific Other Nutrients based Intravenous Solutions Market
Exhibit 108. Other Nutrients based Intravenous Solutions - Asia-Pacific Market - Historic, Current, and Forecast (2010 - 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 109. Other Nutrients based Intravenous Solutions - Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for China, India, Japan, Australia, South Korea and Rest of Asia-Pacific
3.9.5.5 Latin American Other Nutrients based Intravenous Solutions Market
Exhibit 110. Other Nutrients based Intravenous Solutions - Latin American Market - Historic, Current, and Forecast (2010 - 2022) by Country for Brazil, Mexico and Rest of Latin America in US$ Million
Exhibit 111. Other Nutrients based Intravenous Solutions - Latin American Market Shares (2012, 2018 & 2022) by Country for Brazil, Mexico and Rest of Latin America
3.9.5.6 Rest of World Other Nutrients based Intravenous Solutions Market
Exhibit 112. Other Nutrients based Intravenous Solutions - Rest of World Market - Historic, Current, and Forecast (2010 - 2022) by Country for South Africa, Israel and Other Countries in US$ Million
Exhibit 113. Other Nutrients based Intravenous Solutions - Rest of World Market Shares (2012, 2018 & 2022) by Country for South Africa, Israel and Other Countries
3.10 Intravenous Solutions – Market Outlook
4. COMPETITOR DYNAMICS
4.1 Major Global Players in Intravenous Solutions Market
Amanta Healthcare Ltd. (India)
B. Braun Melsungen AG (Germany)
Baxter International, Inc. (USA)
Baxter (India) Pvt. Ltd. (India)
Fresenius Kabi AG (Germany)
ICU Medical, Inc. (USA)
Laboratorios Grifols SA (Spain)
Liqvor Pharmaceuticals (Armenia)
Otsuka Pharmaceutical Co., Ltd. (Japan)
Otsuka Pharmaceutical India Pvt. Ltd. (India)
Sichuan Kelun Pharmaceutical Co., Ltd. (China)
Sino-Swed Pharmaceutical Corp., Ltd. (China)
Terumo Corporation (Japan)
4.2 Competition Analysis
Exhibit 114. Clinical Nutrition Market: 2015 (E) Percentage Market Share of Major Companies
Exhibit 115. Intravenous Solutions Products Market: 2015 Percentage Market Share of Major Companies
Exhibit 116. Companies in Intravenous Solutions Market – Annual Sales for 2013 through 2015
Exhibit 117. Companies in Intravenous Solutions Market – Production Volume and Capacity in Unit/Tonnes/Liters
Exhibit 118. Intravenous Solutions Packaging by Company
Exhibit 119. Intravenous Solutions – Product Comparison
4.3 Major Activities in Intravenous Solutions Market
ICU Medical Acquires Hospira Infusion Systems of Pfizer
Amanta Innovates New Generation IV Fluid System – SteriPort
Amanta Healthcare Receives TGA-Australia Approval for Kheda Facility
Fresenius Kabi Buys BD’s Ready-to-Administer Drugs and US Pharmaceutical Facilities
Fresenius Kabi Expands Plant in Spain
Grifols Unveils New Bioscience Division, in Ireland
Pfizer Purchase Hospira
More….
5. PRODUCT TECHNOLOGY/RESEARCH
5.1 Introduction
Intravenous Solutions
Composition
Exhibit 120. Electrolyte Requirement
Exhibit 121. Contents for Common Fluids (mmol/litre)
Application
Exhibit 122. Fluid Requirements in Different Clinical Situations
Types of Intravenous Solutions
Large Volume Parenterals and Small Volume Parenterals
Exhibit 123. Fluid Comparison
Intravenous versus Oral Mode of Administration
Risks
Precautions
Fat Emulsions
Dextrose
Plasma Expanders
Cyclical Parenteral Nutrition (CPN)
Advantages of Cyclical PN Include
5.2 Segmentation of Intravenous Solutions
Segmentation by Type
Partial Parenteral Nutrition
Total Parenteral Nutrition
Complications
Complications due to Catheter Insertion
Metabolic Complications
Segmentation by Nutrients
Carbohydrates
Carbohydrates - Source of Nutrition
Introduction
Disadvantages of Over-feeding with the Carbon Source
Endogenous Glucose Production and Oxidation
Guidelines
Glucose/Fat Ratio
Salt and Elecrtolytes
Salt (Sodium chloride) and/or Other Electrolytes
Saline
Concentrations
Minerals and Vitamins
Minerals and Vitamins
Amino Acids
Amino Acids and/or Protein Hydrolysates
Dosage of Amino Acids Solutions for Intravenous Use
Other
Fat (lipid) Emulsions
Plasma Extenders
Exhibit 124. List of Agents Administered as IV Solutions or Additives
PACKAGING AND IDENTIFICATION LABELING OF APIS AND INTERMEDIATES
General
Packaging Materials
Label Issuance and Control
Packaging and Labeling Operations
Storage and Distribution
Warehousing Procedures
Distribution Procedures
Specific Guidance for APIs Manufactured by Cell Culture/Fermentation
General
Cell Culture/Fermentation
Harvesting, Isolation and Purification
Viral Removal/Inactivation steps
Safety Assessment of Di (2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices
Safety Assessment of Di (2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices
Conclusions of the Safety Assessment
I V Infusion of Crystalloid Fluids and Drugs
Total Parenteral Nutrition (TPN)
Parenteral Nutrition
Government of India - Policy and Regulations on Drugs
Drug Regulation and Control:
Maharashtra FDA: Latest Reforms
Procedure for Drug Application in India
Import and Manufacturing Licenses and Approvals:
Labeling Requirements
Drug Price Regulation
History of Drug Price Regulation
Trends in Drug Price Control – India
Regulations on Patent Protection
Finale
A Summary of the Chinese Pharmaceutical Market
5.3 Intravenous Solutions – Research Briefs
Supplements of Glucose Greatly Decreases Duration of Induced Labor during Child Birth
A Dose of Dextrose Gel Decreases Risk of Low Blood Sugar in Newborn Babies
A Saline Spray would be as good as Drug Therapy for the Therapy of Nosebleeds
Bloodstream Infections seen in Home Parenteral Nutrition Patients due to Catheter
Several Heart Failure Patients are treated with IV Fluids
More….
6. CORPORATE DIRECTORY
7. PATENTS INFORMATION
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
Analytics and data presented in each report pertain to several parameters such as –
Intravenous Solutions Market research report is analyzed by Type and Nutrients for each of the geographic regions-North America, Europe, Asia-Pacific and Rest of World. The global Intravenous solutions market size includes by Type- Partial Parenteral Nutrition (PPN) & Total Parenteral Nutrition (TPN); by Nutrients-Carbohydrates, Salt and Electrolytes, Minerals and Vitamins and Amino Acids. Historic, current and future markets for the total IV solutions market are given by geographic regions.
